Paudel Mukesh S, Tiwari Awadhesh, Mandal Amrendra, Shrestha Barun, Kafle Paritosh, Chaulagai Baikuntha, Kc Sudhamshu
Gastroenterology, Lumbini City Hospital, Patan, NPL.
Radiology, Lumbini Medical College and Teaching Hospital, Palpa, NPL.
Cureus. 2019 Feb 19;11(2):e4099. doi: 10.7759/cureus.4099.
Background Non-alcoholic fatty liver disease (NAFLD) is the deposition of fat inside liver cells in the absence of secondary causes. It is considered as a hepatic complication of metabolic syndrome. The metabolic syndrome consists of dyslipidemia, hypertension, diabetes, and obesity. This study aims to determine the prevalence of metabolic syndrome in Nepalese patients with NAFLD from mid-Western part of Nepal. Method This was a descriptive cross-sectional study. Three different sites were chosen in and around Butwal sub-metropolitan city of Rupandehi district, Nepal. A one-day health camp for the screening of fatty liver disease by ultrasonography (USG) was conducted at these sites. Participants with fatty liver were then classified into three grades by USG and the presence of metabolic syndrome was assessed by the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) criteria. Results A total of 385 participants with NAFLD were evaluated. Presence of metabolic syndrome by NCEP-ATPIII criteria was found to be in 57.6% participants; whereas, at least one component of metabolic syndrome was found in 91.4% of participants with radiologic features of fatty liver. Higher proportion of patients with NAFLD were males. Increased waist circumference followed by low high-density lipoprotein (HDL) level were the most common components of metabolic syndrome in participants with NAFLD. Conclusions Metabolic syndrome is common in Nepalese community patients with NAFLD.
非酒精性脂肪性肝病(NAFLD)是在无继发性病因情况下肝细胞内脂肪的沉积。它被认为是代谢综合征的一种肝脏并发症。代谢综合征包括血脂异常、高血压、糖尿病和肥胖。本研究旨在确定尼泊尔中西部地区患有NAFLD的尼泊尔患者中代谢综合征的患病率。
这是一项描述性横断面研究。在尼泊尔鲁潘德希区布特瓦尔次都市及其周边地区选择了三个不同地点。在这些地点举办了为期一天的通过超声检查(USG)筛查脂肪性肝病的健康营。然后通过USG将患有脂肪肝的参与者分为三个等级,并根据美国国家胆固醇教育计划成人治疗小组第三次报告(NCEP-ATPIII)标准评估代谢综合征的存在情况。
总共评估了385名患有NAFLD的参与者。根据NCEP-ATPIII标准,发现57.6%的参与者存在代谢综合征;而在具有脂肪肝放射学特征的参与者中,91.4%的人至少有一项代谢综合征组分。患有NAFLD的患者中男性比例更高。腰围增加其次是高密度脂蛋白(HDL)水平降低是患有NAFLD的参与者中代谢综合征最常见的组分。
代谢综合征在尼泊尔社区患有NAFLD的患者中很常见。